SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Delvys Rodríguez-Abreu

Delvys Rodríguez-Abreu

Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria

Prof. Delvys Rodríguez-Abreu is Head of the Medical Oncology Department at Hospital Universitario Insular de Gran Canaria in Las Palmas de Gran Canaria, Spain, and associate professor at the Universidad de Las Palmas de Gran Canaria. His research focuses on thoracic malignancies, particularly immunotherapy and targeted therapy in non-small cell lung cancer. He is a lead investigator on the landmark KEYNOTE-189 trial and serves as scientific coordinator of the International Thoracic Cancer Debates held in Gran Canaria. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Delvys Rodríguez-Abreu

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates